Skip to main content
. 2011 Sep 20;1(4):147–155. doi: 10.1007/s12348-011-0036-8

Table 13.

Incidence of treatment failures at each study visit (ITT)

Treatment Total Day 1 Day 3 Day 7 Day 14
N N % N % N % N %
Nepafenac group 106 2 1.9 2 1.9 2 1.9 2 1.9
Placebo group 105 0 0.0 1 1.0 9 8.6 9 8.6
P value 0.5467 0.3974 0.2001 0.2236

NLMixed model P = 0.6151; main effect of treatment; failure defined as aqueous cells score ≥3 or aqueous flare score = 3 or ocular pain score ≥4